Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00657579 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2009-03-16
Summary
To investigate the dose-response relationship of DE-104 ophthalmic solution in lowering intraocular pressure (IOP) in subjects with Primary Open-Angle Glaucoma or Ocular Hypertension
Conditions
- Open-Angle Glaucoma
- Ocular Hypertension
Interventions
- DRUG
-
DE-104 ophthalmic solution, low concentration
- DRUG
-
DE-104 ophthalmic solution, medium concentration
- DRUG
-
DE-104 ophthalmic solution, high concentration
- DRUG
-
DE-104 vehicle
Sponsors & Collaborators
-
Santen Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Max Age
- 74 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Japan
Study Locations
More Related Trials
-
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
NCT01868126 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
NCT02179008 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study
NCT03216902 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT01279083 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
DE-111 Against Timolol Ophthalmic Solution 0.5%
NCT01342094 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT
NCT01654484 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
NCT04742283 ·Status: COMPLETED ·Phase: PHASE2
-
Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily
NCT03067415 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma
NCT03960866 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
NCT06666855 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
NCT03657797 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost
NCT00637130 ·Status: COMPLETED ·Phase: PHASE2
-
DE-117 Spectrum 5 Study
NCT03697811 ·Status: COMPLETED ·Phase: PHASE3
-
Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma
NCT00443924 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
NCT01157364 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%
NCT01342081 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Study of Safety of H1337 in Healthy Volunteers
NCT06572397 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
NCT03293992 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances
NCT06349759 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
NCT03691662 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients
NCT00069706 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
NCT00069719 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
NCT02059278 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension
NCT01687426 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT
NCT02981446 ·Status: COMPLETED ·Phase: PHASE3